Latest News about mRNA
Recent news which mentions mRNA
Vertex Pharmaceuticals: Buy at the High?
October 26, 2023
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 25, 2023
From Benzinga
From MarketWatch
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 24, 2023
From Benzinga
Moderna’s stock snaps record losing streak as Cathie Wood’s ETF boosts stake by more than $4 million
October 24, 2023
From MarketWatch
YieldMax Boosts Fund Suite With MRNA Option Income Strategy ETF
October 24, 2023
From ETF Trends
Tickers
MRNA
From Motley Fool
The Best Stocks to Invest $5,000 In Right Now
October 24, 2023
From Motley Fool
Amid A Crypto Rally, Cathie Wood's Ark Invest Sells Coinbase, Grayscale Bitcoin Trust, Buys Robinhood Shares
October 23, 2023
From Benzinga
Moderna’s stock suffering record losing streak as ‘investor caution remains high’ over COVID vaccine sales
October 23, 2023
From MarketWatch
3 Healthcare Stocks to Invest in for a Big Shot of Gains
October 23, 2023
From InvestorPlace
3 No-Brainer Stocks to Buy Right Now for Less than $100
October 23, 2023
From Motley Fool
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks This Year?
October 22, 2023
From Motley Fool
From MarketWatch
Why Moderna Stock Is Sinking This Week
October 19, 2023
From Motley Fool
3 Stocks That Are Dead in the Water
October 19, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2023
From Benzinga
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point
October 19, 2023
From Motley Fool
Nvidia, United Airlines, Moderna, Lucid, Bank Of America: Why These Five Stocks Are On Investors' Horizons Today
October 17, 2023
From Benzinga
What's Going On With Moderna Stock?
October 17, 2023
From Benzinga
Do These 5 Words From Pfizer Mean Trouble for Novavax?
October 17, 2023
From Motley Fool
From MarketWatch
From MarketWatch
Moderna confirms COVID sales guidance as shares sink on Pfizer news
October 16, 2023
From MarketWatch
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
October 16, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.